Alx Oncology Holdings Inc

ALXO

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001810182

SEC filings (opens in a new tab)

In the last 90 days, Alx Oncology Holdings Inc insiders filed 0 open-market purchases and 2 sales; 93 institutions reported holding it in 13F filings for Q2 2026, worth $217.9M in total; no superinvestor holds it.

Q2 2024 vs. Q1 2024

How the institutions holding Alx Oncology Holdings Inc changed between Q1 2024 and Q2 2024.

All holders in Q2 2024 All holders in Q1 2024

13F holders of ALXO: Q1 2024 compared with Q2 2024
Measure	Q1 2024	Of which not filed for Q2 2024	Q2 2024	Change
Holders	106	2	112	+8
Shares	45.8M	47.2K	48.6M	+2.90M (+6.3%)
Value	$510.5M	$526.1K	$293.4M	−$216.6M (−42.5%)

2 institutions that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (31)

Institutions that held Alx Oncology Holdings Inc at the end of Q2 2024 but not at the end of Q1 2024.

Institutions new to ALXO in Q2 2024
Institution	Shares	Value	% of portfolio
Paradigm Biocapital Advisors LP	1,575,605	$9.50M	0.36%
Privium Fund Management B.V.	396,966	$2.27M	0.58%
Kennedy Capital Management, Inc.	307,529	$1.85M	0.04%
Point72 Asset Management, L.P.	304,100	$1.83M	0.01%
Jacobs Levy Equity Management, Inc	232,022	$1.40M	0.01%
Cubist Systematic Strategies, LLC	199,441	$1.20M	0.02%
Balyasny Asset Management LLC	44,149	$266.2K	0.00%
Algert Global LLC	41,215	$248.5K	0.01%
Verition Fund Management LLC	32,571	$196.4K	0.00%
Wealth Enhancement Advisory Services, LLC	31,419	$189.5K	0.00%
LMR Partners LLP	25,000	$150.8K	0.00%
Graham Capital Management, L.P.	23,942	$144.4K	0.00%
Sherbrooke Park Advisers LLC	22,172	$133.7K	0.02%
UBS Asset Management Americas Inc	21,823	$131.6K	0.00%
D. E. Shaw & Co., Inc.	18,940	$114.2K	0.00%
Corebridge Financial, Inc.	17,771	$107.2K	0.00%
Occudo Quantitative Strategies LP	16,402	$98.9K	0.02%
Mirae Asset Global ETFs Holdings Ltd.	13,016	$78.5K	0.00%
Engineers Gate Manager LP	12,600	$76.0K	0.00%
Voya Investment Management LLC	11,215	$67.6K	0.00%
HSBC Holdings PLC	10,780	$62.6K	0.00%
Invesco Ltd.	10,290	$62.0K	0.00%
Danske Bank A/S	8,500	$51.3K	0.00%
Caption Management, LLC	6,600	$39.8K	0.00%
STRS Ohio	4,100	$24.7K	0.00%
Russell Investments Group, Ltd.	2,331	$14.1K	0.00%
Point72 (DIFC) Ltd	1,963	$11.8K	0.00%
Smartleaf Asset Management LLC	631	$3.68K	0.00%
Qube Research & Technologies Ltd	571	$3.44K	0.00%
CWM, LLC	85	$1.00K	0.00%
Creekmur Asset Management LLC	4	$24	0.00%

Sold out (23)

Institutions that held Alx Oncology Holdings Inc at the end of Q1 2024 and filed for Q2 2024 without it.

Institutions that sold out of ALXO in Q2 2024
Institution	Shares, Q1 2024	Value, Q1 2024
Cormorant Asset Management, LP	3,142,079	$35.0M
Adage Capital Partners GP, L.L.C.	160,000	$1.78M
Squarepoint Ops LLC	106,356	$1.19M
Los Angeles Capital Management LLC	98,960	$1.10M
HRT Financial LP	59,186	$659.0K
TD Asset Management Inc	49,000	$546.4K
Martingale Asset Management L P	36,195	$403.6K
ExodusPoint Capital Management, LP	23,366	$261.0K
Trexquant Investment LP	20,990	$234.0K
Bridgeway Capital Management, LLC	20,000	$223.0K
Bourgeon Capital Management LLC	19,570	$218.2K
American International Group, Inc.	13,000	$144.9K
Ameriprise Financial Inc	11,535	$128.6K
XTX Topco Ltd	10,911	$121.7K
Gsa Capital Partners LLP	10,289	$115.0K
Forefront Analytics, LLC	10,261	$114.4K
Franklin Resources Inc	10,047	$112.0K
Simplex Trading, LLC	3,514	$39.0K
Metropolitan Life Insurance Co	1,579	$17.6K
Red Tortoise LLC	340	$3.79K
Westend Capital Management, LLC	74	$825
Signaturefd, LLC	20	$223
Nelson, Van Denburg & Campbell Wealth Management Group, LLC	5	$55

Not filed for Q2 2024 yet (2)

Institutions that held Alx Oncology Holdings Inc at the end of Q1 2024 and haven't filed a 13F for Q2 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding ALXO in Q1 2024 that haven't filed for Q2 2024
Institution	Shares, Q1 2024	Value, Q1 2024
Financial Advisory Group	31,417	$350.3K
Credit Suisse AG	15,765	$175.8K